Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2019, and Revision of Full-Year Financial Forecasts(PDF?228KB)

On November 6, 2019 Sysmex Corporation reported that actual financial results during the six months ended September 30, 2019, differed in some respects from the forecast announced on May 8, 2019 (Press release, Sysmex, NOV 6, 2019, View Source [SID1234550402]). In addition, Sysmex has revised its financial forecast for the full fiscal year ending March 31, 2020. These differences are described below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

1. Differences between Actual and Forecast of Consolidated Financial Results for the Six Months Ended September 30, 2019 (April 1, 2019 to September 30, 2019)

3. Reasons for the Differences and Revision

Although sales were robust, both in Japan and overseas, consolidated net sales for the first six months of the fiscal year ending March 31, 2020, were lower than previously forecast, mainly due to the impact of higher-than-anticipated yen appreciation. On the profit front, we worked to curtail selling, general and administrative (SG&A) expenses, but were unable to compensate for the lower-thanexpected sales. For this reason, plus the posting of a foreign exchange loss, operating profit, profit before tax and profit attributable to owners of the parent were lower than previously forecast.

We will continue working to improve profitability and curtail SG&A expenses, but with yen appreciation higher than initially forecast, we have revised downward our forecast for the full fiscal year ending March 31, 2020, as we now expect net sales, operating profit, profit before tax and profit attributable to owners of the parent to be below our previously forecast figures. We have revised the foreign exchange assumptions used for calculating financial forecasts from the third quarter onward from USD1.00 = JPY110, EUR1.00 = JPY125 and CNY1.00 = JPY16.5 to USD1.00 = JPY108, EUR1.00 = JPY120 and CNY1.00 = JPY15.3.